ES8405952A1 - Un metodo de detectar un anticuerpo antivirus - Google Patents

Un metodo de detectar un anticuerpo antivirus

Info

Publication number
ES8405952A1
ES8405952A1 ES525660A ES525660A ES8405952A1 ES 8405952 A1 ES8405952 A1 ES 8405952A1 ES 525660 A ES525660 A ES 525660A ES 525660 A ES525660 A ES 525660A ES 8405952 A1 ES8405952 A1 ES 8405952A1
Authority
ES
Spain
Prior art keywords
reagent
detecting
antivirus antibody
antivirus
carrier particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525660A
Other languages
English (en)
Other versions
ES525660A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Publication of ES8405952A1 publication Critical patent/ES8405952A1/es
Publication of ES525660A0 publication Critical patent/ES525660A0/es
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

METODO PARA DETECTAR UN ANTICUERPO ANTIVIRUS.COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE PONEN EN SUSPENSION PARTICULAS SENSIBILIZADAS DE UN REACTIVO CONSTITUIDO POR PARTICULAS DE UN VEHICULO QUE NO SE AGREGAN EN PRESENCIA DE UN VIRUS QUE TIENE ACTIVIDAD HEMOAGLUTINANTE, Y POR UN ANTIGENO VIRICO QUE TIENE ACTIVIDAD HEMOAGLUTINANTE Y QUE ESTA SENSIBILIZADO SOBRE DICHAS PARTICULAS DE VEHICULO; SEGUNDA, SE MEZCLAS UNA SERIE DE DILUCIONES DE UNA MUESTRA CON DICHA SUSPENSION; Y POR ULTIMO, SE DETERMINA LA PRODUCCION DE LA AGLUTINACION DE DICHAS PARTICULAS SENSIBILIZADAS EN CADA MEZCLA.DE APLICACIONEN LA DETECCION DE ENFERMEDADES VIRICAS CONTAGIOSAS, TALES COMO LA RUBEOLA, EL SARAMPION Y LAS PAPERAS.
ES525660A 1982-09-17 1983-09-16 Un metodo de detectar un anticuerpo antivirus Granted ES525660A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16088682A JPS5951355A (ja) 1982-09-17 1982-09-17 抗ウイルス抗体検出用試薬

Publications (2)

Publication Number Publication Date
ES8405952A1 true ES8405952A1 (es) 1984-06-16
ES525660A0 ES525660A0 (es) 1984-06-16

Family

ID=15724487

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525660A Granted ES525660A0 (es) 1982-09-17 1983-09-16 Un metodo de detectar un anticuerpo antivirus

Country Status (3)

Country Link
EP (1) EP0106495A3 (es)
JP (1) JPS5951355A (es)
ES (1) ES525660A0 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0176638B1 (en) * 1984-10-03 1989-08-23 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Artificial support material for immobilisation of biological protein and process for producing the same
JPS62182662A (ja) * 1986-02-06 1987-08-11 Fujirebio Inc ウイルス抗体検出用試薬
US4924270A (en) * 1987-10-29 1990-05-08 Minolta Camera Kabushiki Kaisha Toner supply device for use in image forming apparatus
JPH079429B2 (ja) * 1988-10-12 1995-02-01 財団法人化学及血清療法研究所 人工担体およびその製造方法
JP2896174B2 (ja) * 1989-10-27 1999-05-31 富士レビオ株式会社 人工担体
DE4014540A1 (de) * 1990-05-07 1991-11-14 Klaus Dr Tschaikowsky Immunkonjugate zur prophylaxe und therapie von organschaeden bei entzuendlichen prozessen
ES2113094T3 (es) * 1993-03-09 1998-04-16 Epic Therapeutics Inc Las microparticulas macromoleculares y metodos de obtencion.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5554730A (en) * 1993-03-09 1996-09-10 Middlesex Sciences, Inc. Method and kit for making a polysaccharide-protein conjugate
EP2662090A1 (en) 2008-04-14 2013-11-13 Halozyme, Inc. Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
TWI394580B (zh) 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
NZ593641A (en) 2008-12-09 2013-01-25 Halozyme Inc Extended soluble ph20 polypeptides and uses thereof
EP2720713A2 (en) 2011-06-17 2014-04-23 Halozyme, Inc. Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme
WO2013040501A1 (en) 2011-09-16 2013-03-21 Pharmathene, Inc. Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826613A (en) * 1973-03-06 1974-07-30 Us Navy Detection and titration of viruses and antibodies using latex
US3957741A (en) * 1974-01-17 1976-05-18 California Institute Of Technology Crosslinked, porous, polyacrylate beads
US4195074A (en) * 1977-03-01 1980-03-25 Abbott Laboratories Process for producing a soluble rubella antigen
EP0001223A3 (en) * 1977-09-19 1979-12-12 F.Hoffmann-La Roche & Co. Aktiengesellschaft Latex coated with a polyhydroxy compound, process for the preparation of this latex, immunological reagent containing this latex, process for the preparation of this reagent, application of this reagent, testing procedure utilising this reagent and reagent kit containing this reagent
EP0062968B2 (en) * 1981-03-18 1991-07-10 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Support material for use in serological testing and process for the production thereof

Also Published As

Publication number Publication date
JPS5951355A (ja) 1984-03-24
EP0106495A2 (en) 1984-04-25
ES525660A0 (es) 1984-06-16
EP0106495A3 (en) 1984-06-06

Similar Documents

Publication Publication Date Title
ES8405952A1 (es) Un metodo de detectar un anticuerpo antivirus
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
ES483313A1 (es) Procedimiento de determinacion inmunologico para un complejoinmunologico
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
ES554453A0 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
FI950002A (fi) Anti-HCV-vasta-aineiden immunomääritykset käyttäen antigeenejä joissa on konformaatioepitooppeja
NO933697L (no) Fremgangsm}te for screening av plasmapr!ver for effektiveantistoff-titere overfor respiratoriske virus
ES8404515A1 (es) Procedimiento de aglutinacion con latex para la deteccion o la determinacion de un participante en una reaccion inmunologica.
ES8802406A1 (es) Un metodo para detectar el anticuerpo para el antigeno superficial de la hepatitis b de subtipona como divisional de la patente de invencion 545.205 del 15-7-85
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE15107T1 (de) Immunochemisches reagenz.
KR850001699A (ko) 성인t세포 백혈병 바이러스 항체 검출용 시약의 제조방법
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
JPS56129862A (en) Production of diagnosis latex reagent
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
MY100476A (en) Supported viral antigen and preparation and use thereof
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
ES8609729A1 (es) Un metodo para detectar la presencia de anticuerpos del vi- rus de la pseudo-rabia en una muestra biologica
FI843562L (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
EP0183215A3 (en) Method for determination of herpes simplex virus antibodies
DK481484A (da) Fremgangsmaade til paavisning af virus
JPS51136820A (en) Immunochemical detection method
Bricout et al. Rubalex test for the detection of rubella antibodies: Limitations.
Han et al. An enhanced hemagglutination inhibition test for detection of mumps antibody.
Zlotowicz et al. Immunofluorescent approach to serological diagnosis of avian leucosis, using the DASS system.